Literature DB >> 31428990

Peripheral polyneuropathy associated with Chikungunya virus infection.

Vanessa P Silva1, Dacylla S Costa1, Vania C C V L Carvalho2, Tereza C C S Garcês3, Emanuela L T Barros1, Jefferson S Oliveira1, Anna C T C Pereira1, Gustavo P Ferreira4.   

Abstract

The Chikungunya virus (CHIKV) is an arbovirus transmitted to humans through mosquito bites and can cause a series of symptoms ranging from a benign febrile illness to severe neurological conditions. We report the identification of CHIKV in a serum sample from an elderly woman with febrile illness and severe arthralgia in Brazil. The occurrence was found of peripheral polyneuropathy affecting the upper and lower limbs evidenced by electroneuromyographic findings. The patient was treated with a corticoid associated with methotrexate, suggesting that the pathophysiological basis of the case in question may be related to an immune-mediated response by T cells and inflammatory cytokines. This finding reinforces the need to be aware of the emergence of neuroinfections related to CHIKV and effective diagnoses for the early detection of neurological alterations, favoring the clinical management of these patients.

Entities:  

Keywords:  Arthralgia; Chikungunya; Polyneuropathy

Mesh:

Substances:

Year:  2019        PMID: 31428990     DOI: 10.1007/s13365-019-00782-7

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   3.739


  12 in total

Review 1.  Vaccine and Therapeutic Options To Control Chikungunya Virus.

Authors:  Ann M Powers
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

2.  Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection.

Authors:  Weiqiang Chen; Suan-Sin Foo; Adam Taylor; Aleksei Lulla; Andres Merits; Linda Hueston; Mark R Forwood; Nicole C Walsh; Natalie A Sims; Lara J Herrero; Suresh Mahalingam
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

Review 3.  The Range of Neurological Complications in Chikungunya Fever.

Authors:  T Cerny; M Schwarz; U Schwarz; J Lemant; P Gérardin; E Keller
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

Review 4.  That Which Bends Up: A Case Report and Literature Review of Chikungunya Virus.

Authors:  Shana M Peper; Benjamin J Monson; Trevor Van Schooneveld; Christopher J Smith
Journal:  J Gen Intern Med       Date:  2015-07-21       Impact factor: 5.128

5.  Immunoglobulin-responsive chikungunya encephalitis: two case reports.

Authors:  Stephanie Suzanne de O Scott; Pedro Braga-Neto; Lícia Pacheco Pereira; Paulo Ribeiro Nóbrega; Francisco de Assis Aquino Gondim; Manoel Alves Sobreira-Neto; Claudia Carvalho Mendes Schiavon
Journal:  J Neurovirol       Date:  2017-06-02       Impact factor: 3.739

Review 6.  The neurological complications of chikungunya virus: A systematic review.

Authors:  Ravi Mehta; Patrick Gerardin; Carlos Alexandre Antunes de Brito; Cristiane Nascimento Soares; Maria Lucia Brito Ferreira; Tom Solomon
Journal:  Rev Med Virol       Date:  2018-04-19       Impact factor: 6.989

7.  Chikungunya outbreak (2017) in Bangladesh: Clinical profile, economic impact and quality of life during the acute phase of the disease.

Authors:  Mohammad Sorowar Hossain; Md Mahbub Hasan; Muhammad Sougatul Islam; Salequl Islam; Miliva Mozaffor; Md Abdullah Saeed Khan; Nova Ahmed; Waheed Akhtar; Shahanaz Chowdhury; S M Yasir Arafat; Md Abdul Khaleque; Zohora Jameela Khan; Tashmim Farhana Dipta; Shah Md Zahurul Haque Asna; Md Akram Hossain; Km Sultanul Aziz; Abdullah Al Mosabbir; Enayetur Raheem
Journal:  PLoS Negl Trop Dis       Date:  2018-06-06

Review 8.  Neurotropic virus infections as the cause of immediate and delayed neuropathology.

Authors:  Martin Ludlow; Jeroen Kortekaas; Christiane Herden; Bernd Hoffmann; Dennis Tappe; Corinna Trebst; Diane E Griffin; Hannah E Brindle; Tom Solomon; Alan S Brown; Debby van Riel; Katja C Wolthers; Dasja Pajkrt; Peter Wohlsein; Byron E E Martina; Wolfgang Baumgärtner; Georges M Verjans; Albert D M E Osterhaus
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

9.  Individual and contextual risk factors for chikungunya virus infection: the SEROCHIK cross-sectional population-based study.

Authors:  A Fred; A Fianu; M Béral; V Guernier; D Sissoko; M Méchain; A Michault; V Boisson; B-A Gaüzère; F Favier; D Malvy; P Gérardin
Journal:  Epidemiol Infect       Date:  2018-05-03       Impact factor: 4.434

Review 10.  Cellular and Molecular Immune Response to Chikungunya Virus Infection.

Authors:  Ithallo S B Tanabe; Eloiza L L Tanabe; Elane C Santos; Wanessa V Martins; Isadora M T C Araújo; Maria C A Cavalcante; Ana R V Lima; Niels O S Câmara; Leticia Anderson; Dinar Yunusov; Ênio J Bassi
Journal:  Front Cell Infect Microbiol       Date:  2018-10-10       Impact factor: 5.293

View more
  2 in total

1.  Carbohydrates: Binding Sites and Potential Drug Targets for Neural-Affecting Pathogens.

Authors:  Cara-Lynne Schengrund
Journal:  Adv Neurobiol       Date:  2023

2.  Common Dysregulation of Innate Immunity Pathways in Human Primary Astrocytes Infected With Chikungunya, Mayaro, Oropouche, and Zika Viruses.

Authors:  Victor Emmanuel Viana Geddes; Otávio José Bernardes Brustolini; Liliane Tavares de Faria Cavalcante; Filipe Romero Rebello Moreira; Fernando Luz de Castro; Ana Paula de Campos Guimarães; Alexandra Lehmkuhl Gerber; Camila Menezes Figueiredo; Luan Pereira Diniz; Eurico de Arruda Neto; Amilcar Tanuri; Renan Pedra Souza; Iranaia Assunção-Miranda; Soniza Vieira Alves-Leon; Luciana Ferreira Romão; Jorge Paes Barreto Marcondes de Souza; Ana Tereza Ribeiro de Vasconcelos; Renato Santana de Aguiar
Journal:  Front Cell Infect Microbiol       Date:  2021-03-15       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.